APOE and Alzheimer disease: Clinical investigations suggest that the ApoE4 homozygous genotype is linked to a notably elevated risk of AD, and ApoE4 carriers encounter a 20% higher likelihood of experiencing depressive symptoms compared to noncarriers [44,46,58–63].